Therapeutic Advances in Drug Safety

期刊全称

期刊缩写

THER ADV DRUG SAF

涉及主题

医学生物内科学药理学心理学精神科病理重症监护医学不利影响化学外科政治学法学护理部数学药品生物化学统计经济遗传学家庭医学内分泌学

期刊介绍

Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in drug safety, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across all areas of drug safety, including therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics and regulation.

期刊ISSN

print: 2042-0986 on-line: 2042-0994

历年影响因子

2024年	2023年	2022年	2021年	2020年	2019年	2018年	2017年
3.4	4.4	3.216	3.842	3.463	0	0	0

历年发表/被引量

年份	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
发表量	22	68	51	28	35	38	35	52	51	35	32	29
被引量	2	148	242	239	572	652	1270	1228	1796	1519	1041	1237

自引率

5.90%

涉及的研究领域

Medicine-Pharmacology (medical)

2026年新锐分区

大类	小类	TOP期刊	综述期刊
2区	2区药学	否	N/A

中科院2025年分区

大类	小类	TOP期刊	综述期刊
3区	3区药学	否	否

WOS期刊分区

JCR学科分类

JCR分区学科名称	收录数据库	JCR分区	分区排名
PHARMACOLOGY & PHARMACY	SCIE	Q2	113/352

JCI学科分类

JCI分区学科名称	收录数据库	JCI分区	分区排名
PHARMACOLOGY & PHARMACY	SCIE	Q2	144/353

期刊主页

https://journals.sagepub.com/home/taw https://us.sagepub.com/en-us/nam/journal/therapeutic-advances-drug-safety

出版商

SAGE

出版国家（地区）

ENGLAND

出版语言

English

每年出版文章数

Gold OA文章占比

94.38%

原创研究文献占比
(排除综述)

66.67%

SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

Directory of Open Access Journals (DOAJ)

PubMed链接

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2042-0986%5BISSN%5D

平均审稿周期

9 Weeks

Therapeutic Advances in Drug Safety

JCR学科分类

JCI学科分类

期刊相关文献 (565)

The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patients

质子泵抑制剂与 CDK4/6 抑制剂阿贝西利联合用药不会影响转移性乳腺癌患者的临床结局。

Metformin-associated lactic acidosis in an elderly diabetic patient without classical risk factors: a case report

老年糖尿病患者服用二甲双胍后发生乳酸性酸中毒，且无典型危险因素：病例报告

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database

COVID-19 抗病毒药物用药错误及相关严重后果：一项基于 FDA 不良事件报告系统数据库的真实世界研究

Safety and risk management in clinical trials for chronic wounds with tissue regenerative products

组织再生产品治疗慢性伤口临床试验中的安全性和风险管理

General practitioner-pharmacist collaboration to enhance deprescribing of psychotropics, sedatives, and anticholinergics among older polypharmacy patients in primary care: study protocol of a cluster-randomized controlled trial (PARTNER)

全科医生与药剂师合作，加强对初级保健中老年多重用药患者减少精神药物、镇静剂和抗胆碱能药物的处方：一项整群随机对照试验的研究方案（PARTNER）

Prevalence of potentially inappropriate medication use and its association with hospitalization among older adults with chronic disease in the Amhara region, Ethiopia: a multicenter prospective cohort study

埃塞俄比亚阿姆哈拉州老年慢性病患者潜在不合理用药的流行情况及其与住院治疗的关系：一项多中心前瞻性队列研究

Effect of ciprofol-assisted sedation on tourniquet-related responses in foot and ankle surgery: a randomized clinical trial

环丙酚辅助镇静对足踝手术中止血带相关反应的影响：一项随机临床试验

Integration of pre‑existing cardiovascular comorbidity into CDK4/6 inhibitor selection for breast cancer

将既往心血管合并症纳入乳腺癌 CDK4/6 抑制剂的选择中

Prevalence and predictors of prescribing errors in a primary care setting in Ghana

加纳基层医疗机构处方错误的发生率及预测因素

Drug-induced intestinal obstruction: insights from the FDA Adverse Event Reporting System

药物引起的肠梗阻：来自FDA不良事件报告系统的启示